A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells

被引:453
作者
Anders, Lars [1 ,3 ]
Ke, Nan [1 ,3 ]
Hydbring, Per [1 ,3 ]
Choi, Yoon J. [1 ,3 ]
Widlund, Hans R. [5 ]
Chick, Joel M. [4 ]
Zhai, Huili [6 ]
Vidal, Marc [1 ,2 ,3 ]
Gygi, Stephen P. [4 ]
Braun, Pascal [1 ,2 ,3 ]
Sicinski, Piotr [1 ,3 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA
[6] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
关键词
TRANSCRIPTION FACTOR FOXM1C; CELLULAR SENESCENCE; BREAST-CANCER; TUMOR-SUPPRESSOR; CYCLIN; PROGRESSION; INHIBITION; TRANSITION; MECHANISMS; MELANOMA;
D O I
10.1016/j.ccr.2011.10.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin D-dependent kinases (CDK4 and CDK6) are positive regulators of cell cycle entry and they are over-active in the majority of human cancers. However, it is currently not completely understood by which cellular mechanisms CDK4/6 promote tumorigenesis, largely due to the limited number of identified substrates. Here we performed a systematic screen for substrates of cyclin D1-CDK4 and cyclin D3-CDK6. We identified the Forkhead Box M1 (FOXM1) transcription factor as a common critical phosphorylation target. CDK4/6 stabilize and activate FOXM1, thereby maintain expression of G1/S phase genes, suppress the levels of reactive oxygen species (ROS), and protect cancer cells from senescence. Melanoma cells, unlike melanocytes, are highly reliant on CDK4/6-mediated senescence suppression, which makes them particularly susceptible to CDK4/6 inhibition.
引用
收藏
页码:620 / 634
页数:15
相关论文
共 36 条
[1]   Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion [J].
Ackermann, Amanda M. ;
Gannon, Maureen .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2007, 38 (1-2) :193-206
[2]   The landscape of somatic copy-number alteration across human cancers [J].
Beroukhim, Rameen ;
Mermel, Craig H. ;
Porter, Dale ;
Wei, Guo ;
Raychaudhuri, Soumya ;
Donovan, Jerry ;
Barretina, Jordi ;
Boehm, Jesse S. ;
Dobson, Jennifer ;
Urashima, Mitsuyoshi ;
Mc Henry, Kevin T. ;
Pinchback, Reid M. ;
Ligon, Azra H. ;
Cho, Yoon-Jae ;
Haery, Leila ;
Greulich, Heidi ;
Reich, Michael ;
Winckler, Wendy ;
Lawrence, Michael S. ;
Weir, Barbara A. ;
Tanaka, Kumiko E. ;
Chiang, Derek Y. ;
Bass, Adam J. ;
Loo, Alice ;
Hoffman, Carter ;
Prensner, John ;
Liefeld, Ted ;
Gao, Qing ;
Yecies, Derek ;
Signoretti, Sabina ;
Maher, Elizabeth ;
Kaye, Frederic J. ;
Sasaki, Hidefumi ;
Tepper, Joel E. ;
Fletcher, Jonathan A. ;
Tabernero, Josep ;
Baselga, Jose ;
Tsao, Ming-Sound ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Janne, Pasi A. ;
Daly, Mark J. ;
Nucera, Carmelo ;
Levine, Ross L. ;
Ebert, Benjamin L. ;
Gabriel, Stacey ;
Rustgi, Anil K. ;
Antonescu, Cristina R. ;
Ladanyi, Marc ;
Letai, Anthony .
NATURE, 2010, 463 (7283) :899-905
[3]   Signatures of mutation and selection in the cancer genome [J].
Bignell, Graham R. ;
Greenman, Chris D. ;
Davies, Helen ;
Butler, Adam P. ;
Edkins, Sarah ;
Andrews, Jenny M. ;
Buck, Gemma ;
Chen, Lina ;
Beare, David ;
Latimer, Calli ;
Widaa, Sara ;
Hinton, Jonathon ;
Fahey, Ciara ;
Fu, Beiyuan ;
Swamy, Sajani ;
Dalgliesh, Gillian L. ;
Teh, Bin T. ;
Deloukas, Panos ;
Yang, Fengtang ;
Campbell, Peter J. ;
Futreal, P. Andrew ;
Stratton, Michael R. .
NATURE, 2010, 463 (7283) :893-U61
[4]   E2F target genes: unraveling the biology [J].
Bracken, AP ;
Ciro, M ;
Cocito, A ;
Helin, K .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (08) :409-417
[5]   Proteome-scale purification of human proteins from bacteria [J].
Braun, P ;
Hu, YH ;
Shen, BH ;
Halleck, A ;
Koundinya, M ;
Harlow, E ;
LaBaer, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :2654-2659
[6]   Cellular senescence: when bad things happen to good cells [J].
Campisi, Judith ;
di Fagagna, Fabrizio d'Adda .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (09) :729-740
[7]   Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure [J].
Dean, J. L. ;
Thangavel, C. ;
McClendon, A. K. ;
Reed, C. A. ;
Knudsen, E. S. .
ONCOGENE, 2010, 29 (28) :4018-4032
[8]   FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer [J].
Francis, Richard E. ;
Myatt, Stephen S. ;
Krol, Janna ;
Hartman, Johan ;
Peck, Barrie ;
McGovern, Ursula B. ;
Wang, Jun ;
Guest, Stephanie K. ;
Filipovic, Aleksandra ;
Gojis, Ondrej ;
Palmieri, Carlo ;
Peston, David ;
Shousha, Sami ;
Yu, Qunyan ;
Sicinski, Piotr ;
Coombes, R. Charles ;
Lam, Eric W. -F. .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (01) :57-68
[9]  
Fry DW, 2004, MOL CANCER THER, V3, P1427
[10]   Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma [J].
Garraway, LA ;
Widlund, HR ;
Rubin, MA ;
Getz, G ;
Berger, AJ ;
Ramaswamy, S ;
Beroukhim, R ;
Milner, DA ;
Granter, SR ;
Du, JY ;
Lee, C ;
Wagner, SN ;
Li, C ;
Golub, TR ;
Rimm, DL ;
Meyerson, ML ;
Fisher, DE ;
Sellers, WR .
NATURE, 2005, 436 (7047) :117-122